MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2024 International Congress

    Real-World Multicenter Analysis of Levodopa Equivalent Daily Dosage Algorithms- Capturing Geographical and Demographic Disparities in Parkinson’s Disease Therapy Spanning Six Countries and Two Continents

    P. Kukkle, L. Kalia, A. Habib, P. Jagota, R. Ojha, R. Kandadai, S. Desai, M. Caldera, D. Sirisena, D. Garg, T. Mestre, R. Neupane, S. Maytharakcheep, K. Sanyawut, R. Borgohain (Bangalore, India)

    Objective: To assess the influence of updated Levodopa Equivalent Daily Dosage (LEDD) conversion factors in capturing the newer therapies in Parkinson’s Disease (PD) and therapy…
  • 2024 International Congress

    Examination of how DaTscan Impacts Diagnosis in Parkinsonian Patients with and without Dopamine Receptor Blocking Agent Exposure

    R. Lopez-Castellanos, S. Factor, R. Blakes (Atlanta, USA)

    Objective: To determine whether Dopamine transporter imaging impacts diagnosis in parkinsonian patients Background: Dopamine transporter imaging (DaTscan) is a diagnostic tool used to assess loss…
  • 2024 International Congress

    A novel G413S mutation in the CSF1R gene causes Hereditary Diffuse Leucoencephalopathy with axonal Spheroids; clinically overlapping features of Parkinsonism

    ANW. Ullah, MZB. Badshah (Peshawar, Nepal)

    Objective: The current study was designed to investigate the genetic cause of atypical Parkinsonism is a multigenerational Pakistani family Background: Hereditary Diffuse Leucoencephalopathy with axonal…
  • 2024 International Congress

    Genome-wide Survival Analysis Identified Association Between HS1BP3 and APOE loci and Dementia in Parkinson’s disease

    S. Jo, J-H. Oh, J. Lee, S. Son, CO. Sung, SJ. Chung (Seoul, Republic of Korea)

    Objective: We aim to conduct a genome-wide survival study (GWSS) to identify single nucleotide polymorphisms (SNP) associated with dementia in Parkinson’s disease (PD) with a…
  • 2024 International Congress

    Neuroprotective Action of Exogenous Melatonin in Parkinson Disease Patients and its Impact on Daily Routine: a Systematic Review

    G. Maia, P. Silva, M. Rosa, R. Albuquerque, E. Almeida, C. Menegon, V. Serafim, F. Oliveira, G. Sorato, I. Fink, C. Rieder (Porto Alegre, Brazil)

    Objective: This study aims to evaluate the neuroprotective action of exogenous melatonin in Parkinson disease patients and its impact on daily routine. Background: Parkinson Disease…
  • 2024 International Congress

    Effect of rehabilitation therapy on the motor functions in patients with multiple system atrophy

    J. Lee, S. Jo, M. Choi, SJ. Chung (Seoul, Republic of Korea)

    Objective: We aim to evaluated the effect of rehabilitation therapy on the motor symptoms and activities of daily living in patients with MSA using an…
  • 2024 International Congress

    Cardiovascular Associations of Cortical Lewy Bodies in the Oldest Old: The 90+ study

    R. Rajmohan, Z. Al-Darsani, N. Phielipp, T. Montine, M. Corrada, C. Kawas (Orange, USA)

    Objective: To identify potential risk factors for cortical Lewy Bodies (CLB) in the oldest-old (> 90 years old), we investigated if cardiovascular medical histories, medication…
  • 2024 International Congress

    New onset movement disorders following COVID-19 infection

    D. van Wamelen, B. Facer, S. Rota, M. Bonello, K. Chaudhuri, G. Breen, B. Michael (London, United Kingdom)

    Objective: To determine the prevalence and phenotype of movement disorders following SARS-CoV-2 infection in hospitalised individuals. Background: Although movement disorders, including parkinsonism, following SARS-CoV-2 (COVID-19)…
  • 2024 International Congress

    Delayed Parkinsonism as a Delayed Neurological Sequele in Carbon Monoxide Intoxication: A Rare Case Report

    CP. Gasmara, A. Tiksnadi, D. Tunjungsari (DKI Jakarta, Indonesia)

    Objective: To report delayed onset parkinsonism in carbon monoxide intoxication. Background: Secondary parkinsonism as a delayed neurological sequel (DNS) after gas or chemical substance exposure…
  • 2024 International Congress

    Blood Pressure Profile of PD-MCI and PDD in Parkinson’s Disease Patients at Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia

    A. Al Jody, A. Tiksnadi, D. Tunjungsari (Jakarta, Indonesia)

    Objective: This study aims to explore the BP profile in both PD-MCI and PDD Background: Blood pressure (BP) abnormality is often correlated with cognitive impairment. However,…
  • « Previous Page
  • 1
  • …
  • 27
  • 28
  • 29
  • 30
  • 31
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley